Most patients who experience arthritic sequelae after enterobacterial infection express the human leukocyte antigen (HLA) class I histocompatibility antigen HLA-B27 (7) . Reactive arthritis and Reiter's syndrome are often preceded by gastroenteritis involving specific gram-negative pathogens, most notably Shigella, Salmonella, Yersinia, and Campylobacter species (8) . Although an antecedent episode of infection is not characteristic of ankylosing spondylitis, chronic habitation of the bowel, particularly by Klebsiella pneumoniae, is suspected (21) . Of the theories proposed to explain the expression of a particular MHC haplotype and susceptibility to postinfectious spondyloarthritic lesions, molecular mimicry emerges as a potential pathogenic mechanism. Autoreactive humoral and cellular immune responses may be induced by persistent bacterial antigens sharing cross-reactive epitopes with the mimicked host protein, in this case the HLA-B27 molecule.
Serologic cross-reactivity between class I antigens and arthritogenic bacteria has been demonstrated with polyvalent rabbit and human antisera and monoclonal anti-HLA-B27 antibodies. How'ever, a review of previous studies reveals descrepant results between laboratories, even when similar reagents and techniques are used. For example, using sera from rabbits immunized with lymphocytes from HLA-B27-positive subjects, Welsh et al. (42) demonstrated immunologic cross-reactivity against several gram-negative enteric pathogens, including K. pneumoniae and Yersinia enterocolitica; however, Archer (3) , using the same antisera, failed to confirm these results. To overcome problems associated with high levels of nonspecific binding inherent to the use of whole antisera, several groups, including our own, have used two well-characterized monoclonal anti-HLA-B27 antibodies (B27.M1 and B27.M2) to identify cross-reactive bacterial epitopes. Van Bohemen et al. (38) trifugation as described previously (29) . Total protein content was determined by the method of Lowry et al., modified for membrane-associated proteins (24) .
Production of monoclonal antibodies. BALB/c female mice were inoculated in multiple subcutaneous sites with 100 ,ug of total protein suspended in 0.1 ml of normal saline. Mice were rested for 1 month and then given a final intraperitoneal inoculum of 100 ,ug of total protein. The immunogen for all fusions was whole bacterial envelopes prepared from S. flexneri 2a isolated from a patient with Reiter's syndrome (SSU 6335). Splenocytes were fused with syngeneic plasmacytoma cells P3x63.Ag8.653) as described by Kohler and Milstein (19) and modified by Kennett (17) and Oi and Herzenberg (26) , with polyethylene glycol 1500 (BoehringerMannheim Biochemicals, Indianapolis, Ind.) as the fusogen. Positive hybridomas were cloned by using the Epics CS flow cytometer equipped with an autoclone accessory. Antibodies were isotyped by radial immunodiffusion by using rabbit anti-mouse subclass-specific antisera (Binding Site, Inc., San Diego, Calif.). Ascites fluids were produced as previously described (15) . Immunoglobulin M (IgM) was purified from ascites fluids by Sephadex G200 (Pharmacia Fine Chemicals, Piscataway, N.J.) chromatography followed by hypoosmotic precipitation by dialysis of IgM-containing fractions against 1 mM Tris hydrochloride (pH 7.5).
Synthetic polypeptides. HOM-2 (22) 2. HOM-2 cells, which are homozygous at the HLA-B locus, were strongly positive when stained with a saturating concentration of each of the four test monoclonal antibodies. By contrast, Daudi and K562 cells, which lack cell surface expression of class I molecules, were uniformly negative (Fig. 1 ). MM cells displayed a level of surface fluorescence comparable to that of HOM-2 cells. The mutant cell line 1065, which was derived from the HLA-B27-positive cell line MM but does not express for HLA-B locus antigens, was also tested. Although the antibodies stain MM cells more brightly, the 1065 cells demonstrated observable levels of fluorescence staining (Fig. 1) . The transfected cell line EB-1, which expresses surface HLA-B7, was also positive with all four test monoclonal antibodies; however, cells transfected with and expressing HLA-A2 (EA-6) and the parental cell line (EL-4) were negative (Fig. 1) .
To characterize the molecular basis for antibody activity, synthetic polypeptides were produced with an amino acid sequence identical to the variable region-spanning residues 63 through 83 of the HLA-B*2705, HLA-B7, and HLA-B40 heavy chains ( (Fig. 2) . Antibodies were nonreactive with two synthetic peptides of unrelated sequence, which were included as negative controls (data not shown).
Membrane proteins of the HLA-B27-positive cell line MM were extracted with detergent, resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and transferred to nitrocellulose for Western blot analysis with the HLAreactive monoclonal antibody (Fig. 3) . All monoclonal antibodies bound to a protein with a molecular mass of approximately 44 kDa, which is identical to that of the MHC class I heavy chain. A protein of similar molecular mass was identified by the B27-specific IgM monoclonal antibody B27.M2, which was included as a positive control. Other isotype controls were nonreactive by Western blotting.
When tested by immunoblotting with electrophoretically resolved S. flexneri 2a membrane proteins, each of the four HLA-reactive monoclonal antibodies gave an identical pattern of reactivity. A major reactive protein was observed at 36 kDa, and a less prominent band was seen at 19 Neither protein reacted with antibody D1D8, which was included as an isotype control (Fig. 4) . To determine whether the cross-reactive epitope was unique to this isolate of S. flexneri, envelope proteins were prepared from a collection of S. flexneri strains representing most serotypes and from a group of related bacteria, some of which are also epidemiologically associated with arthritic disease. These preparations were standardized for protein concentration and tested by ELISA with the monoclonal antibody. Positive activity against bacterial strains was observed with the HLA-reactive monoclonal antibodies ( Table 4 ). The isotype control was specific for S. flexneri 2a. Although the reaction of antibody C7E10 was weaker than that of the remaining three antibodies, no preferential binding was seen with any strains tested.
DISCUSSION
Despite the epidemiologic evidence associating gram-negative members of the family Enterobacteriaceae with the seronegative spondyloarthropathies, the mechanism by which bacterial factors can initiate and perpetuate these diseases remains hypothetical. Furthermore, in contemplating pathogenic mechanisms, equal consideration must be given to genetic factors, such as the presence of the class I histocompatibility antigen HLA-B27, which undoubtedly predisposes individuals to postinfectious arthritic sequelae (6) . The results presented in this report demonstrate that monoclonal antibodies prepared against an arthritogenic organism also recognize epitopes present on class I histocompatibility antigen. This supports the hypothesis that the link between environmental and genetic etiologic factors is a common immunodeterminant and that this molecular mimicry could be of pathologic significance in the induction of chronic arthritic disease.
The four cross-reactive monoclonal antibodies were initially identified by using cultured cell lines in an indirect microfluorometric assay. Although previous investigators have used a microcytotoxicity assay to determine HLA specificity of their monoclonal antibodies (20) , we tried to avoid any potential problems associated with complementbinding capabilities of the monoclonal antibodies. The four monoclonal antibodies had similar patterns of reactivity against the cultured cell lines. Antibodies were completely negative against cells lacking MHC class I antigens (Daudi, K562, EL-4) and against murine lymphoid cells transfected with and expressing only HLA-A2 (EA-6). Monoclonal antibodies were not, however, singularly positive with HLA-B27-positive cells; they were equally reactive with transfectants expressing only HLA-B7 (EB-1) and nominally reactive with cells lacking HLA-B antigen but expressing HLA-A24 and HLA-C2 (1065). This low degree of allelic specificity indicates that the epitope recognized by these antibodies consists of nonpolymorphic residues shared by several HLA class I antigens. We can also conclude that this epitope differs from that recognized by B27.M2, which is specific for B27 and Bw47 (5) . Although it appears that our monoclonal antibodies bind preferentially with B-locus antigens, fluorescence intensity between cultured lymphocytes may not be directly comparable, because the surface density of HLA antigen may vary from one cell line to another.
In Western blot analyses against detergent-extracted MM (HLA-B27-positive) cells, all four cross-reactive monoclonal antibodies bound to a single band at an approximate molecular mass of 44 kDa. This molecular mass corresponds to that previously reported for the MHC class I heavy chain and is identical to that observed when monoclonal antibody B27.M2 is subjected to immunoblot analysis. Based on ELISA results with synthetic polypeptides corresponding to amino acids 63 through 83 of the class I heavy chain, we determined that the epitope recognized by our monoclonal antibodies was present in this segment. Previous investigators have shown that this polymorphic sequence also contains the epitope responsible for specific binding of B27.M2 (5) and recognition structures for allospecific cytotoxic T lymphocytes (2, 41) . Although this segment would appear critical in defining allospecificity of the HLA-B27 molecule, significant structural homology exists between the HLA-B27 variable region and the corresponding segment of non-HLA-B27 class I molecules (32) . Several nonpolymorphic epitopes within the variable region have been identified by using monoclonal antibodies generated against lymphocytic cells (1, 11, 27, 28, 31) . The existence of such epitopes would explain the reactivity of our four monoclonal antibodies with non-HLA-B27 class I antigen and in particular with the HLA-B7 and HLA-B40 synthetic polypeptides, which were also derived from their respective variable regions. The presence of such epitopes may also explain the high incidence of HLA-B7 CREG (cross-reactive group) antigens in HLA-B27-negative spondyloarthritic patients (4, 18) . Using S. flexneri envelope proteins, we observed qualitatively identical patterns of immunoblot reactivity for the four monoclonal antibodies. The reactive epitope was present on 36-and 19-kDa antigen of S. flexneri, but was not restricted to this species of the family Enterobacteriaceae. Strong ELISA activity was observed with all strains tested, even with species generally considered nonarthritogenic (e.g., E. coli). Despite the presence of such antigens, additional bacterial virulence mechanisms (such as the ability to invade host cells and survive intracellularly) are also characteristic of species with arthritogenic potential. Indeed, the ability of an organism to establish infection is a prerequisite for host exposure to and immune system recognition of cross-reactive antigens. The occurrence of a cross-reactive epitope that is present on many organisms is consistent with the (35, 36, 39) . Serum antibodies of the IgG, IgM, and IgA classes directed against Yersinia proteins of 35 to 36 kDa have been reported in patients with reactive arthritis after infection with Y. enterocolitica (12, 33, 40) , but whether this antigen corresponds to the 36-kDa antigen recognized by our cross-reactive monoclonal antibody is yet to be determined. The availability of monoclonal antibodies will facilitate purification of this antigen for further studies with patient specimens.
Of greater interest is the potential regulatory role of bacterially induced HLA class I-reactive antibodies on Tcell responses in a susceptible host. Several monoclonal anti-class I HLA antibodies, in the presence of adherent antigen-presenting cells, can inhibit mitogen-and antigeninduced T-cell proliferation (9, 10, 37 
